ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY

Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascul...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1443-A1443
Hauptverfasser:	Chandrasekhar, Jaya, Colombo, Antonio, Aquino, Melissa, Ong, Tiong Kiam, Ge, Zhen, Farhan, Serdar, Lee, Michael Kang Yin, Iniguez, Andres, Joyce, Lauren, Snyder, Clayton, Sartori, Samantha, Baber, Usman, Morrell, Debbie, Elmore, Francesca, Rowland, Stephen, Mehran, Roxana
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioengineering Cardiology Clinical outcomes Diabetes Diabetes mellitus Implants Mascots Stents Surgical implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!